Conferences Crossfire Oncology is attending in 2026
Crossfire Oncology is listed at 2 conferences on Tnuki's calendar in 2026: PEGS Europe 2026 (on the program) and ENA 2026 (on the program). Crossfire Oncology is a Dutch company developing kinase-targeting inhibitors, degraders and degrader-antibody conjugates for cancer. As of Oct 17, 2026.
| Conference | Details | Involvement | Tnuki guide |
|---|---|---|---|
PEGS Europe 2026 — Protein & Antibody Engineering SummitEurope’s protein & antibody engineersOfficial site |
Lisbon, Portugal ~1.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 talk Attendee mix: Mostly biopharma; protein and antibody engineers, biologics developers and discovery group leaders
Attending
|
Open the guide Search and filter attendees |
38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer TherapeuticsCancer drug discovery & early-development scientistsOfficial site |
Barcelona, Spain ~1.5k attendees | On the programNo booth or sponsorship in the organizer’s published lists Program 1 poster Attendee mix: Mostly biopharma; preclinical and translational oncology scientists, phase I investigators and chemists, some academics
Attending
|
Open the guide Search and filter attendees |
We hold published exhibitor, sponsor, program or attendee lists for 54 of the 156 conferences on our calendar, so this page shows Crossfire Oncology’s involvement at those 54 only — it is not a complete record of where they go. Organizers typically publish a list around six months before the event, so coverage grows over time.
Instantly find decision makers at Crossfire Oncology
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!